However, the methylation level in these positions is similar in the corresponding normal tissues (Figure 4A), ruling out the possibility that a differential methylation of these sites can be responsible for the downregulation of B4GALNT2 in cancer. The gene discussed is B4GALNT2; the disease is cancer.